The global Methylphenidate Market witnessed robust growth in 2021 and is expected to maintain a high compound annual growth rate (CAGR) throughout the forecast period. This growth is primarily driven by the increasing use of methylphenidate in psychiatry for attention deficit hyperactivity disorder (ADHD) due to its mood stabilizing benefits, as well as its adoption in narcolepsy therapies as a stimulant.
https://www.reportsanddata.com..../report-detail/methy
Like
Comment
Share
